Active ingredientFoscarnet SodiumCat. No. P-F118-001CAS 63585-09-1Family · Pharmaceutical analytical standards
Foscarnet
An antiviral that mimics pyrophosphate and occupies its binding site on viral DNA polymerases; approved in 1991, it is used mainly for cytomegalovirus retinitis and for herpesviruses resistant to other drugs. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?Unlike aciclovir and ganciclovir it does not need to be activated by viral enzymes: it works as it is, which is why it is also effective against strains resistant to those drugs.
Go to the active ingredient →Active ingredientFoscarnet SodiumCat. No. P-F118-001CAS 63585-09-1
Active ingredientFoscarnet Sodium HexahydrateCat. No. P-F118-002CAS 34156-56-4
Pharmacopoeial impurityFoscarnet Sodium EP Impurity ACat. No. P-F118-003CAS 72305-00-1
Pharmacopoeial impurityFoscarnet Sodium EP Impurity B (as Disodium Salt)Cat. No. P-F118-004CAS 55920-24-6
Pharmacopoeial impurityFoscarnet Sodium EP Impurity CCat. No. P-F118-005CAS 72304-94-0
Pharmacopoeial impurityFoscarnet Sodium EP Impurity DCat. No. P-F118-006CAS 1474-78-8No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
ImpurityFoscarnet impurity B CRSEDQM code F0389004Family FoscarnetImpurityFoscarnet impurity D CRSEDQM code Y0001222Family FoscarnetReference substanceFoscarnet sodium hexahydrate CRSEDQM code F0389000Family FoscarnetNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.